-
NMPA and NHC Issued the Announcement on Good Clinical Practice
2020-04-26
NMPA, in conjunction with NHC, has organized the revision of the Good Clinical Practice (GCP), which has been released on April 26, 2020, and shall enter into effect as from July 1, 2020.
-
NMPA Announcement on the Release of Revised Draft of the Appendix (Biological Products) as Recorded in the Good Manufacturing Practice for Drugs (Revised in 2010)
2020-04-26
NMPA has,in the light of Article 310 of the Good Manufacturing Practice for Drugs (Revised in 2010), revised the Appendix (Biological Products) (as a supporting document for the GMP), which has been released on April 26, 2020, and will come into force on July 1, 2020.
-
NMPA and NHC Issued Regulations for Administration of Medical Device Extended Clinical Trials (Interim)
2020-03-20
NMPA has, in conjunction with NHC formulated and released on March 20, 2020 the Regulations for Administration of Medical Device Extended Clinical Trials (Interim).
-
NMPA Issued the Notice on Strengthening the Supervision and Inspection of Sterile and Implantable Medical Devices
2020-04-14
On April 14, 2020, NMPA issued the Notice on Strengthening the Supervision and Inspection of Sterile and Implantable Medical Devices.
-
NMPA Issued the Announcement on the Guidance for Medical Device Registrants to Conduct Adverse Events Monitoring
2020-04-10
NMPA has organized the formulation of and released on April 10, 2020 the Guidance for Medical Device Registrants to Conduct Adverse Events Monitoring.
-
NMPA Issued the Announcement on Issues Pertaining to the Current Administration on Drug Distribution
2020-04-03
On April 3, 2020, NMPA issued the Announcement on Issues Pertaining to the Current Administration on Drug Distribution.